Later, Craft et al. conducted a randomized-controlled trial with intranasal insulin administration and found that intranasal insulin improved delayed memory and preserved caregiver-rated functional ability in mild cognitive impairment patient[71]. This evidence concerns the gene INS and Cognitive impairment.